Kalinin N E, Ali S H, Dymov A M, Chinenov D V, Akopyan G N, Gazimiev M A
Institute of Urology and Human Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
National Medical Research Center of Urology on Urology, Moscow, Russia.
Urologiia. 2023 Mar(1):71-75.
An important aspect of the prevention of complications in percutaneous nephrolithotomy (PCNL) is to reduce the likelihood of injury to the adjacent structures and perirenal tissues.
To determine the efficiency and safety of renal puncture during mini-PCNL with a new atraumatic needle MG.
A total of 67 patients who underwent mini-percutaneous nephrolithotomy at the Institute of Urology and Human Reproductive Health of Sechenov University were included in the prospective study. For the purpose of homogeneity of the groups, those with staghorn nephrolithiasis, nephrostomy, a history of prior kidney surgery (including PCNL), renal and collecting system anomalies, acute pyelonephritis, and blood clotting disorders were not included. The main group consisted of 34 (50.7%) patients who underwent atraumatic kidney puncture with a new needle MG (MIT, Russia), while in the control group there were 33 (49.3%) patients, who underwent standard puncture with Chiba or Troakar needles (Coloplast A/S, Denmark). The outer diameter of all needles was 18 G.
In patients with a standard access, a hemoglobin decrease in the early postoperative period was more pronounced (p=0.024). The incidence of complications according to the Clavien-Dindo classification did not differ significantly (p=0.351), however, a JJ stent was placed in two patients from the control group due to impaired urine flow and the development of urinoma.
Together with a similar stone-free rate, atraumatic needle allows to reduce a hemoglobin drop, as well as less development of severe complications.
经皮肾镜取石术(PCNL)预防并发症的一个重要方面是降低损伤相邻结构和肾周组织的可能性。
确定使用新型无创伤针MG进行微创经皮肾镜取石术(mini-PCNL)时肾穿刺的有效性和安全性。
前瞻性研究纳入了67例在谢马什克大学泌尿外科与人类生殖健康研究所接受微创经皮肾镜取石术的患者。为使各组具有同质性,排除了鹿角形肾结石、肾造瘘、既往有肾脏手术史(包括PCNL)、肾脏和集合系统异常、急性肾盂肾炎以及凝血障碍的患者。主要组由34例(50.7%)使用新型MG针(俄罗斯MIT公司)进行无创伤肾穿刺的患者组成,而对照组有33例(49.3%)患者,他们使用千叶针或Troakar针(丹麦科洛普拉斯公司)进行标准穿刺。所有针的外径均为18G。
在采用标准入路的患者中,术后早期血红蛋白下降更为明显(p=0.024)。根据Clavien-Dindo分类法,并发症发生率无显著差异(p=0.351),然而,对照组有两名患者因尿流受阻和尿瘤形成而置入了双J支架。
在结石清除率相似的情况下,无创伤针可减少血红蛋白下降,以及减少严重并发症的发生。